The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Covidien Announces Investor Meeting Agenda

Thursday, August 30, 2012

Covidien Announces Investor Meeting Agenda07:00 EDT Thursday, August 30, 2012 DUBLIN (Business Wire) -- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Thursday, September 13, 2012. The event will be held at Cipriani, 55 Wall Street, New York, NY. A webcast of the presentations will begin at 1:40 pm ET and the webcast will conclude by 5:00 pm ET. The program will include presentations by Covidien's Chairman, President and Chief Executive Officer José (Joe) E. Almeida and Chief Financial Officer Charles J. Dockendorff, as well as Q&A with members of the senior management team. For those investors who are unable to attend the meeting in person, but who would like to ask a question of the management team during the meeting, questions can be emailed to Agenda     11:00 a.m.       Registration Opens; Product Displays; Senior Management Reception 1:40 p.m. Formal program begins –   José (Joe) E. Almeida, Chairman, President and CEO – Healthcare Reform / Reimbursement Panel Discussion – Moderated by Dr. Michael Tarnoff, Covidien Corporate Chief Medical Officer – Q&A with Senior Management Team   4:10 p.m. Charles J. Dockendorff, Chief Financial Officer 4:30 p.m. Financial Q&A 5:00 p.m. Presentations and webcast end   Advance registration is required to attend in person and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website: Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien's website: A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting. ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 43,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit to learn more about our business. CovidienEric Kraus, 508-261-8305Senior Vice PresidentCorporate Communicationseric.kraus@covidien.comorBruce Farmer, 508-452-4372Vice PresidentPublic Relationsbruce.farmer@covidien.comorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor Relationscole.lannum@covidien.comorTodd Carpenter, 508-452-4363DirectorInvestor